Patents
Patents for C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
12/2004
12/29/2004EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/28/2004US6835844 Acrylic esters and use thereof
12/23/2004WO2004052316A3 Novel skin lightening agents, compositions and methods
12/23/2004US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis
12/23/2004DE10255242A9 Verfahren zur Reinigung von Liponsäure A process for purifying lipoic acid
12/22/2004CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/15/2004EP1486495A1 Lipoic acid derivatives and their use in treatment of disease
12/15/2004EP1485115A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
12/14/2004US6831093 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
12/09/2004US20040249098 (Meth)acrylic and (meth)acrylamide monomers comprising cyclic acetal/thioacetal groups, polymerizable compositions, and polymers obtained
12/09/2004US20040248877 Inducing apoptosis in tumor cells
12/07/2004US6827876 Using alpha, alpha -difluorocyclohexylidene derivative as starting material to obtain difluoromethyl ether derivative
12/02/2004US20040242901 Sulfoniun salts, methods for their preparation and use thereof as phtoinitiators for radiation curable systems
12/01/2004EP1480969A1 Dithiolane derivatives for immobilizing biomolecules on noble metals and semiconductors
12/01/2004EP1480967A1 Novel fused ring compounds, and their use as cationic photoinitiators
12/01/2004EP1246625B1 Uses and compositions of nitrate esters for providing sedation
11/2004
11/25/2004US20040236116 Novel bicyclic and tricyclic cannabinoids
11/23/2004US6822062 Supported group 8-10 transition metal olefin polymerization catalysts
11/23/2004US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004US6821529 Oligo(ethylene glycol)-terminated 3-alkyl-1,2-dithiolane for use as part of support in chemical analysis
11/18/2004WO2004099162A1 Polycyclic diazodioxide-based bcl-2 protein antagonist
11/18/2004WO2004098582A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
11/16/2004US6818775 Treatment of skin-related diseases or prevention of certain undesired side effects of administered retinoids
11/11/2004US20040225007 Different physicochemical properties with different X-ray diffraction patterns; antiinflammatory and cytoprotective agent, treat diabetes mellitus and insulin resistance, glucose metabolic disorders of the central nervous system and appetite suppressant
11/10/2004EP1474131A1 Use of anethole dithiolethione in lung cancer chemoprevention
11/04/2004WO2004094403A1 Basic salt of thioctic acid with l-carnitine
11/04/2004US20040220271 Fungicidal active compound combinations
11/04/2004US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004DE10318045A1 Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung Stable ammonium salts of the alpha-lipoic acid, their preparation and use
11/03/2004CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
10/2004
10/28/2004WO2004092157A1 STABLE AMMONIUM SALTS OF α-LIPONIC ACID, THE PRODUCTION THEREOF AND THE USE OF THE SAME
10/28/2004US20040214879 Basic salt of thioctic acid with L-carnitine
10/28/2004CA2522470A1 Stable ammonium salts of .alpha.-liponic acid, the production thereof and the use of the same
10/21/2004WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/20/2004EP1467983A1 Method for producing thioctic acid
10/20/2004EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
10/19/2004US6806024 Oxime derivatives and the use thereof as photoinitiators
10/14/2004US20040202930 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
10/13/2004CN1537109A Novel modifications of aminobutantriol salt of r-thioctic acid and method for producing the same
10/13/2004CN1537088A Transfer hydrogenation process and catalyst
10/13/2004CN1535964A 5,7,12,14-tetroxodibenzothianthrene organic third-order non-linear optical material and its chemical synthesis method
10/13/2004CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid
10/07/2004US20040194548 Sensitive and selective method and device for the detection of trace amounts of a substance
09/2004
09/30/2004WO2004050084A3 Ace-inhibitors having antioxidant and nitricoxid-donor activity
09/29/2004CN1533386A Slfonium salts, methods for their preparation and use therof as photoinitiators for radiation curable systems
09/28/2004US6797731 Resorcinol derivatives
09/23/2004WO2003079403A3 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/22/2004EP1458667A1 Method for the production of dihydroxycarboxylate esters
09/22/2004EP1124820B1 Lipoic acid derivatives and their use in treatment of disease
09/21/2004US6794471 Acrylic ester compound usage thereof
09/16/2004WO2004078908A2 Alpha-keto carbonyl calpain inhibitors
09/16/2004DE19806354B4 Verwendung von α-Liponsäure oder deren physiologisch verträgliche Salze zur Behandlung von LDL-Hypercholesterinämie Use of α-lipoic acid or its physiologically acceptable salts for the treatment of hypercholesterolemia LDL
09/16/2004CA2518020A1 Alpha-keto carbonyl calpain inhibitors
09/15/2004EP1341746B1 Liquid crystalline compounds
09/15/2004EP1133487B1 Antioxidants
09/14/2004US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction
09/10/2004WO2004077511A2 (meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained
09/08/2004EP1454627A1 Alpha-Keto carbonyl calpain inhibitors
09/07/2004US6787062 Reacting bis(alkylthio)carbenium salt with hydroxyl compound in presence of base; fluorination and oxidation
09/01/2004EP1452521A1 Cyclic compound and ppar agonist
08/2004
08/26/2004WO2004060971A3 Sulfide-containing polythiols
08/24/2004US6780477 Liquid crystalline compounds
08/19/2004WO2004069774A2 Synthesis of 13c-labelled estrogen analogues
08/19/2004US20040162304 Estrogen receptor modulators
08/18/2004EP0984928A4 Aromatic and heterocyclic nitrato derivatives
08/17/2004US6776994 Synergistic mixtures
08/05/2004US20040152817 Molecular weight control of polymers with wear resistance and oxidation resistance of methylvinylene polymers for lubricants
08/04/2004EP1443061A1 Sulfurized polyisobutylene based wear and oxidation inhibitors
07/2004
07/29/2004US20040147598 Cardiovascular disorders; angina pectoris
07/28/2004EP1440158A1 Method for the production of (r)- and (s)-8-chloro-6-hydroxy-octanic acid alkyl esters by enzymatic reduction
07/28/2004EP0823897B1 Nicotinic acid esters and pharmaceutical compositions containing them
07/28/2004EP0823895B1 Fatty acid esters as bioactive compounds
07/22/2004WO2004060971A2 Sulfide-containing polythiols
07/22/2004WO2004060951A1 High impact poly(urethane urea) polysulfides
07/22/2004US20040143090 Sulfide-containing polythiols
07/22/2004US20040142993 Viricides
07/22/2004US20040142989 Viricides
07/22/2004CA2502710A1 Sulfide-containing polythiols
07/22/2004CA2500379A1 High impact poly(urethane urea) polysulfides
07/20/2004US6764777 Sulfur-containing compound and light-emitting device using same
07/15/2004US20040138401 High impact poly (urethane urea) polysulfides
07/14/2004CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated
07/14/2004CN1157115C Antifungal active compound compsns.
07/08/2004US20040132693 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE)
07/01/2004WO2004055000A1 Multifunctional cationic photoinitiators, their preparation and use
07/01/2004WO2004024681A3 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
07/01/2004US20040127658 Productivity catalysts and microstructure control
07/01/2004US20040127576 Estrogen receptor modulators
07/01/2004US20040127469 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
06/2004
06/29/2004US6756354 Stabilization of drugs
06/24/2004WO2004052316A2 Novel skin lightening agents, compositions and methods
06/24/2004US20040120907 Novel skin lightening agents, compositions and methods
06/24/2004DE10351434A1 Preparation of 2-alkyl-6-(het)aryl-difluoromethoxy-naphthalene, -tetralin and -decalin compounds, for liquid crystal display, involves converting naphthalene compound into carboxylic acid derivative and reaction with phenol compound
06/17/2004WO2004050594A1 Method for producing naphthalene derivatives
06/17/2004WO2004050084A2 Ace-inhibitors having antioxidant and nitricoxid-donor activity
06/16/2004EP1330449B1 Process for the production of racemic thioctic acid
06/16/2004EP1110943B1 6-fluorobicyclo 3. 1.0]hexane derivatives
06/15/2004US6750338 Process for making 5-substituted pyrazoles
06/15/2004US6750213 Bone disorders; urogenital system disorders; anticancer agents
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 34